Is Ekf Diagnostics Holding plc a buy as shares jump 10%+?

Should you add Ekf Diagnostics Holding plc (LON: EKF) to your portfolio?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Point-of-care specialist EKF Diagnostics (LSE: EKF) has released an upbeat trading update today with plenty of good news on revenues, earnings and investment plans. But does that mean now is the right time to buy it?

EKF’s third quarter of the year was a successful one. It was materially higher than budget and at a run-rate above and beyond market forecasts. EKF now expects to record revenues and adjusted EBITDA (earnings before interest, tax, depreciation and amortisation) for 2016 that will exceed even the high end of current market forecasts.

5 Stocks For Trying To Build Wealth After 50

One notable billionaire made 99% of his current wealth after his 50th birthday. And here at The Motley Fool, we believe it is NEVER too late to start trying to build your fortune in the stock market. Our expert Motley Fool analyst team have shortlisted 5 companies that they believe could be a great fit for investors aged 50+ trying to build long-term, diversified portfolios.

Click here to claim your free copy now!

Additionally, EKF has also announced that its cash generation during the third quarter has been strong and its net debt position has therefore been boosted considerably. Although EKF is expected to continue to invest for long-term growth through to the end of the year, it now expects to be cash positive within the next year. Crucially, this won’t be to the detriment of capex to increase consumables capacity in Germany and to replace equipment in the US.

The market has reacted positively to EKF’s update. Its shares are up by 15% and this takes them to a rise of 52% in the last six months. Looking ahead, there could be more capital gains to come, since EKF offers stunning earnings growth forecasts at a very reasonable price.

For example, EKF is expected to turn a profit in the current year after five years of straight losses. Next year, its bottom line is forecast to rise by 134% and this puts it on a price-to-earnings growth (PEG) ratio of just 0.3. This indicates that it offers significant upward rerating potential and it would therefore be unsurprising for it to continue to beat the wider index.

Upbeat outlook

Of course, there are other options within the healthcare space. A notable example is Smith & Nephew (LSE: SN). It offers a lower risk profile than EKF since it has an excellent track record of profitability. It also has a much stronger balance sheet, superior cash flow and greater diversity in terms of its product offering and geographic exposure.

Furthermore, Smith & Nephew offers an upbeat outlook. Its bottom line is expected to grow by 13% in the next financial year and this puts it on a PEG ratio of just 1.4. This shows that while Smith & Nephew is a large cap that may not be able to compete with smaller peers in terms of growth, it nevertheless offers substantial capital gain potential.

In fact, Smith & Nephew’s risk/reward ratio is more appealing than that of EKF. Certainly, EKF is worth buying due to its rapid improvement, growth prospects and low valuation. However, Smith & Nephew’s lower risk and still relatively high reward prospects make it the better overall investment for the long term.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Senior woman wearing glasses using laptop at home
Investing Articles

SSE shares are up 15% since the market correction! Should I buy?

Jabran Khan looks at why SSE shares have been on an upward trajectory in recent weeks and decides if he…

Read more »

One English pound placed on a graph to represent an economic down turn
Investing Articles

After crashing 29%, Spectris shares look cheap to me

After peaking at 4,167p last September, Spectris shares have slumped by over 29%. But I see deep value in the…

Read more »

British Pennies on a Pound Note
Investing Articles

Here is why I added this dirt-cheap FTSE 100 penny stock to my holdings!

Jabran Khan explains why he added this dirt-cheap FTSE 100 stock to his holdings and is excited by its recovery…

Read more »

Woman looking at a jar of pennies
Investing Articles

3 FTSE 100 penny stocks! Which is the cheapest buy?

Our writer examines three penny stocks that feature in the FTSE 100 index to ascertain whether they have a place…

Read more »

Arrowings ascending on a chalkboard
Investing Articles

Is the Vodafone share price an opportunity at current levels?

Jabran Khan looks at the current Vodafone share price and decides if he would add the shares to his holdings…

Read more »

Smiling senior white man talking through telephone while using laptop at desk.
Investing Articles

4 gems I’d include in my Stocks & Shares ISA

Jon Smith explains some of the top stocks he's thinking about including in his Stocks and Shares ISA a we…

Read more »

Compass pointing towards 'best price'
Investing Articles

At 85p, are Rolls-Royce shares a no-brainer buy? 

The Rolls-Royce share price look very cheap right now. And I think this might be my last chance to buy…

Read more »

positive mental health woman
Investing Articles

My £3-a-day blue-chip passive income plan

Our writer sets out his passive income plan of investing a few pounds each day in top stocks.

Read more »